Phase-III-support-Carcinogenicity

Carcinogenicity

We have long-held experience of conducting carcinogenicity studies in the pharmaceutical and chemical industry sectors; having undertaken them for more than 30 years. Studies are run in our purpose built rodent facilities where technologists have well-honed skills in dosing over prolonged periods and in palpation of masses.

Pathology is critical for the successful outcome of these studies and we employ three full-time toxicological pathologists with combined experience amounting to over six decades, including extensive carcinogenicity study experience. The qualifications of our pathologists are detailed below:

Pathologist A: BDS(Edin) DipRCPath (Tox) FRCPath
Pathologist B: BSc PhD DipRCPath (Tox) FRCPath
Pathologist C: DVM MRCVS

Statistical analysis is overseen by one of the leading UK experts in this field.